BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 18601902)

  • 21. Regulation of somatodendritic dopamine release by corticotropin-releasing factor via the inhibition of voltage-operated Ca2+ channels.
    Kim Y; Park MK; Chung S
    Neurosci Lett; 2009 Nov; 465(1):31-5. PubMed ID: 19729048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release.
    Chen BT; Moran KA; Avshalumov MV; Rice ME
    J Neurochem; 2006 Feb; 96(3):645-55. PubMed ID: 16405515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-threshold L-type calcium channels in rat dopamine neurons.
    Durante P; Cardenas CG; Whittaker JA; Kitai ST; Scroggs RS
    J Neurophysiol; 2004 Mar; 91(3):1450-4. PubMed ID: 14645383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamate-mediated [Ca2+]c dynamics in spontaneously firing dopamine neurons of the rat substantia nigra pars compacta.
    Choi YM; Kim SH; Uhm DY; Park MK
    J Cell Sci; 2003 Jul; 116(Pt 13):2665-75. PubMed ID: 12746490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two pathways for the activation of small-conductance potassium channels in neurons of substantia nigra pars reticulata.
    Yanovsky Y; Zhang W; Misgeld U
    Neuroscience; 2005; 136(4):1027-36. PubMed ID: 16203104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voltage-operated Ca2+ channels regulate dopamine release from somata of dopamine neurons in the substantia nigra pars compacta.
    Kim Y; Park MK; Chung S
    Biochem Biophys Res Commun; 2008 Sep; 373(4):665-9. PubMed ID: 18601902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.
    Bustos G; Abarca J; Campusano J; Bustos V; Noriega V; Aliaga E
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):126-44. PubMed ID: 15572168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity-dependent regulation of the dopamine phenotype in substantia nigra neurons.
    Aumann T; Horne M
    J Neurochem; 2012 May; 121(4):497-515. PubMed ID: 22356203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatodendritic dopamine release: recent mechanistic insights.
    Rice ME; Patel JC
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1672):. PubMed ID: 26009764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innervation of the substantia nigra.
    Misgeld U
    Cell Tissue Res; 2004 Oct; 318(1):107-14. PubMed ID: 15338269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium homeostasis, selective vulnerability and Parkinson's disease.
    Chan CS; Gertler TS; Surmeier DJ
    Trends Neurosci; 2009 May; 32(5):249-56. PubMed ID: 19307031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voltage-Gated Ca
    Ortner NJ
    Front Synaptic Neurosci; 2021; 13():636103. PubMed ID: 33716705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic transmitter release: a comparison of two model systems.
    Bergquist F; Ludwig M
    J Neuroendocrinol; 2008 Jun; 20(6):677-86. PubMed ID: 18601689
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.